← Open Payments lookup

SANDRA CHARLES: Open Payments

NPI 1366187882 · KENDALLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$184 in 11 payments from 11 companies in 2025. Trend: 2023 $806 · 2024 $445 · 2025 $184

Food & beverage: $184
CompanyPaymentsAmount
Astellas Pharma US Inc1$25
Sumitomo Pharma America, Inc.1$21
Corium, LLC1$19
Novo Nordisk Inc1$18
ABBVIE INC.1$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
Lilly USA, LLC1$15
Takeda Pharmaceuticals U.S.A., Inc.1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$14
GlaxoSmithKline, LLC.1$14

Products named: Veozah, GEMTESA, Azstarys, Ozempic, QULIPTA, XIFAXAN, MOUNJARO, TRINTELLIX.

Industry payments across IN — which companies pay providers there.